Namaste! Ek professional Equity Research Analyst ke taur par, maine Shilpa Medicare Ltd. ka latest publicly available internet data (as of 22 February 2026) fetch karke deep fundamental analysis prepare kiya hai. Maine primary sources (Screener.in aur Yahoo Finance) ke saath-saath recent Q3 FY26 (Dec 2025) ke earnings concall aur exchange filings ko use kiya … Read more
Ye analysis Jubilant Ingrevia Ltd. ke liye hai. Date of Analysis: February 4, 2026 Current Market Price (CMP): ₹652.00 (Approx) Latest Result: Q3 FY26 (Dec 2025) – Declared Today (Feb 4, 2026) 📑 Equity Research Report: Jubilant Ingrevia Ltd. 1️⃣ Business Model & Work Jubilant Ingrevia ek integrated Life Science products aur Specialty Chemicals company … Read more
Professional Equity Research Report: Gland Pharma Limited (GLAND) Date: January 28, 2026 Analyst Role: Equity Research Analyst Sources: Screener.in, BSE Filings (Q3 FY26 Results declared today), Investor Presentations. Executive Summary Gland Pharma India ki ek unique pharmaceutical company hai jo B2B (Business-to-Business) model par kaam karti hai. Unlike Sun Pharma or Cipla, ye apni branding … Read more